glp 1 tirzepatide vs. Semaglutide: What You Should Know 1+GIP — tailored just to you. Semaglutide & Tirzepatide Weight Loss

A report from PricewaterhouseCoopers found that GLP-1 drugs drove a disproportionate share of the $50 billion hike in pharmacy spending in 2024 (up from a $20 billion increase in 2023)

Take Uber for example - many believed Uber would have a capped upside given the limited market size of the taxi business, but ultimately the company proved to be correct and won big

But its not a simple problem of low GLP-1 = bad

Loss due to disruption is unacceptable anywhere in the industry, and the disruption over the last several years has led us to create systems capable of handling any challenge, no matter the severity

GLP-1RA cause weight loss in a dose-dependent manner, possibly through early satiety and delayed gastric emptying

(2025, December 9)